Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 6:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 319 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Respiratory Illness Clear all

Conditions: Acute Respiratory Failure
Interventions: Personalized SpO2 Target, Usual Care; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Critical Illness, Sleep, Acute Lung Injury, Acute Respiratory Distress Syndrome
Interventions: Dexmedetomidine, Midazolam and Fentanyl; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 85 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 2
States / cities: Tucson, Arizona

Conditions: Pneumonia, Critical Illness
Interventions: Not listed
Lead sponsor: Critical Care Pharmacotherapy Trials Network; Other
Eligibility: 18 Years to 89 Years
Enrollment: 679 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 29
States / cities: Little Rock, Arkansas • Hartford, Connecticut • Jacksonville, Florida + 24 more

Conditions: Healthy, Chronic Stable Illness
Interventions: Casirivimab+Imdevimab; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Miami, Florida • Winter Park, Florida

Conditions: COPD, Heart Failure, Cancer
Interventions: Storytelling Intervention for Patient Participants, Storytelling Intervention for Nurse Participants; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Other Acute Illnesses Presenting to the Hospital, Heart Failure, Pneumonia, Deep Venous Thrombosis, Cellulitis, Abdominal Aortic Aneurysm, Acute Cholecystitis, Peritoneal Free Fluid, Hydronephrosis, Pleural Effusion, Urinary Retention
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Respiration, Artificial, Critical Illness, Chronic Disease, Exercise Therapy, Rehabilitation, Physical Therapy Modalities
Interventions: multimodal physical therapy; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 20 Years to 100 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer, Lung Cancer, Genito Urinary Cancer
Interventions: End-of-life conversation game called "Hello"; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Influenza Prevention, Pandemic Influenza Prevention
Interventions: VRC-FLUMOS0122-00-VP, ALFQ; Biological · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: COVID-19, ARDS, Withdrawal Syndrome, Iatrogenic Disease
Interventions: Not listed
Lead sponsor: Wilkes University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 353 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Wilkes-Barre, Pennsylvania

Conditions: Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism, Trauma
Interventions: The Angel® Catheter; Device
Lead sponsor: BiO2 Medical; Industry
Eligibility: 18 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Los Angeles, California • San Diego, California • Loveland, Colorado + 18 more

Conditions: Acute Respiratory Failure
Interventions: Thiamine; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Apnea, Sleep, Chronic Fatigue Syndrome
Interventions: Nasal CPAP treatment during sleep; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 32 Years to 52 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Northport, New York

Conditions: Healthy
Interventions: SARS-CoV-2/Influenza/RSV RT-PCR; Diagnostic Test
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 9,151 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Acute Respiratory Failure
Interventions: Preoxygenation with Non-Invasive Positive Pressure Ventilation, Facemask Oxygen; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 16
States / cities: Birmingham, Alabama • Aurora, Colorado • Iowa City, Iowa + 13 more

Conditions: Asthma, Childhood Asthma
Interventions: PEF Feedback, Control Feedback; Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 10 Years to 17 Years
Enrollment: 363 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Influenza
Interventions: Not listed
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 17 Years to 55 Years
Enrollment: 2,018 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2023
U.S. locations: 5
States / cities: San Diego, California • Bethesda, Maryland • San Antonio, Texas + 2 more

Conditions: Acute Respiratory Failure, Critical Illness
Interventions: Muscle Ultrasound and Muscle Sample; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Critically Ill, Respiratory Failure
Interventions: Thiamine; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dementia, Chronic Disease, Neoplasm Metastasis, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive, Heart Failure, Congestive, Liver Cirrhosis, Kidney Failure, Chronic, Lung Diseases, Interstitial, Peripheral Vascular Disease, Diabetes With End Organ Injury
Interventions: Survey-based Patient/Clinician Jumpstart, EHR-based Clinician Jumpstart; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 756 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Seattle, Washington

Conditions: Influenza, Respiratory Syncytial Viruses, Paramyxoviridae Infections, Coronavirus, Rhinovirus
Interventions: N95 Respirator, Medical/surgical mask; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 2,862 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 7
States / cities: Aurora, Colorado • Denver, Colorado • Washington D.C., District of Columbia + 3 more

Conditions: Critical Illness, Wounds and Injury, Disease Attributes, Pathologic Processes
Interventions: Automated Titration (O2matic); Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Aurora, Colorado • Winston-Salem, North Carolina • Portland, Oregon + 1 more

Conditions: Depression, Heart Failure, Chronic Obstructive Pulmonary Disease
Interventions: Combined Psychotherapy and Illness Management, Illness Management Only; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 55 Years and older
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Iowa City, Iowa

Conditions: Acute Respiratory Illness, Viral Respiratory Infection
Interventions: MBP® Breath Analyzer; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 7 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Examination of Personalized SpO2 Targets

Sleep Intervention During Acute Lung Injury

Drug Resistance Factors In Healthcare-associated Pneumonia

COVID-19 Study Assessing the Safety and Tolerability of Co-Formulated Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) in Adult Volunteers

Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness

Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program

Development of a Rehabilitation Strengthening and Mobility Program for Ventilator Dependent Older Patients

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

The Angel® Catheter Pivotal Clinical Trial

Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness

Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Pragmatic Trial Examining Oxygenation Prior to Intubation

Childhood Asthma Perception Study

Acute Respiratory Infection Consortium

Muscle Ultrasound Signifies Condition Upgrade Leading Approach to Recovery

The Effect of Thiamine vs. Placebo on VO2 in Critical Illness

Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)

The Respiratory Protection Effectiveness Clinical Trial

Strategy to Avoid Excessive Oxygen Using an Autonomous Oxygen Titration Intervention

Combined Illness Management and Psychotherapy in Treating Depressed Elders

Vocxi Breath Analyzer Study in Pediatric Respiratory Infection